Massimo Balestri è responsabile di Roche Diabetes Care per la Sub-Region Western Europe, che include Spagna, Portogallo, Olanda, Belgio, Svezia, Norvegia, Finlandia, Danimarca. Roche Diabetes Care è un'azienda del gruppo Roche leader nello sviluppo di tecnologie e servizi innovativi per la gestione del Diabete. Dopo la laurea in Economia Politica e un Master in Management della Distribuzione, ha iniziato la sua carriera nell'ambito del Marketing del Baby Food in Plasmon, ricoprendo diversi ruoli. Dal 1997 è in Roche, dove si è occupato prima di Direzione Marketing, poi di Direzione Vendite, fino a diventare responsabile della struttura a livello nazionale dal 2004, come Country Manager/General Manager. Ha maturato esperienza internazionale nel coordinamento di Working Group permanenti di interfaccia tra la Region e Global. Ha anche gestito il business Diabetes Care di Grecia, Slovenia e Croazia nell'ambito del Management Center Italy. È fermamente convinto che il successo delle organizzazioni dipenda dalla Cultura e dall'Engagement che la Leadership è in grado di coltivare e sviluppare nelle persone che la compongono.
%22%20transform%3D%22translate(.7%20.7)%20scale(1.36719)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20fill%3D%22%23393939%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-47.60326%208.43518%20-44.49226%20-251.0885%20231%2068.5)%22%2F%3E%3Cellipse%20fill%3D%22%23bdbdbd%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-57%2082%20-11.7)%20scale(66.10913%20147.64158)%22%2F%3E%3Cellipse%20fill%3D%22%23ededed%22%20cy%3D%2215%22%20rx%3D%2247%22%20ry%3D%2237%22%2F%3E%3Cellipse%20fill%3D%22%23232323%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(12.48183%20-33.40589%2020.92513%207.8185%20245.8%20165.5)%22%2F%3E%3Cpath%20fill%3D%22%236a6a6a%22%20d%3D%22M56.4%20124.1l31.8-3.9%205.4%2043.7-31.8%203.9z%22%2F%3E%3Cellipse%20fill%3D%22%23777%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(17.85348%20-4.2533%2025.33393%20106.3407%20181.1%2089.6)%22%2F%3E%3Cellipse%20fill%3D%22%239d9d9d%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-32.84075%206.62702%20-3.48784%20-17.28428%20255%2057.2)%22%2F%3E%3Cellipse%20fill%3D%22%23b0b0b0%22%20cx%3D%22128%22%20cy%3D%22171%22%20rx%3D%2236%22%20ry%3D%2222%22%2F%3E%3Cellipse%20fill%3D%22%23b1b1b1%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(36.21464%2022.2218%20-7.34621%2011.97204%2020%20136.4)%22%2F%3E%3Cpath%20fill%3D%22%23d4d4d4%22%20d%3D%22M114.6%20102L98.8%2066.5l14.6-6.5%2015.8%2035.7z%22%2F%3E%3Cellipse%20fill%3D%22%238c8c8c%22%20cx%3D%22183%22%20cy%3D%22111%22%20rx%3D%2222%22%20ry%3D%2244%22%2F%3E%3Cellipse%20fill%3D%22%23232323%22%20cx%3D%22246%22%20rx%3D%2219%22%20ry%3D%2212%22%2F%3E%3Cellipse%20fill%3D%22%23f4f4f4%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-15.03176%2016.28103%20-15.51495%20-14.32447%207.7%201.6)%22%2F%3E%3Cellipse%20fill%3D%22%234f4f4f%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(10.18207%201.62798%20-3.2416%2020.27432%20203.2%20167.7)%22%2F%3E%3Cellipse%20fill%3D%22%236e6e6e%22%20cx%3D%22137%22%20rx%3D%2265%22%20ry%3D%2225%22%2F%3E%3Cpath%20fill%3D%22%23a0a0a0%22%20d%3D%22M151.4%2062.6l-10-23.5L117%2019.4-16%2056.7z%22%2F%3E%3Cellipse%20fill%3D%22%23767676%22%20cx%3D%2224%22%20cy%3D%22179%22%20rx%3D%2269%22%20ry%3D%2217%22%2F%3E%3Cpath%20fill%3D%22%23585858%22%20d%3D%22M185%2043l23-59h-61z%22%2F%3E%3Cellipse%20fill%3D%22%239e9e9e%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(29.8088%20-51.21663%2029.69898%2017.28522%20134%20134)%22%2F%3E%3Cellipse%20fill%3D%22%239d9d9d%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-127.1%2046.5%2029.6)%20scale(41.66416%2061.81484)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Tutti gli articoli
FASE 2/ Balestri (Roche): riprogrammazione, la parola chiave per la ripartenza
Roche Diabetes Care è tra le aziende che non ha fermato la propria attività durante l'emergenza e ora affronta la ...
